News
As its obesity medication Wegovy loses a sizable portion of the market to Eli Lilly and Company (NYSE:LLY)’s competing ...
Viking Therapeutics offers leaner operations, lower complexity, faster trial execution, and less execution risk. Learn more ...
Pharmalittle: We’re reading about FDA eyeing PDUFA changes, compounded weight loss drugs, and more
Online weight loss company Noom has begun offering smaller doses of compounded versions of Novo Nordisk's Wegovy ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback